Open replacement of heart valves (all valves)
Ask the expert
The report presents a summary of reimbursement situation for open replacement of heart valves (aortic, mitral, tricuspid and pulmonary).
Report includes information about two types of prosthetic heart valves:
- biological valves
- mechanical prosthetic valves
Open replacement of heart valves will be analyzed in conjunction with open coronary artery bypass grafting (CABG).
The following indications will be considered:
- Aortic stenosis
- Mitral insufficiency
- Tricuspid insufficiency
- Pulmonary valve insufficiency
The only reimbursement within public / statutory health insurance systems is considered.
Report includes essential information about reimbursement and national funding, including:
- Brief overview of reimbursement system for medical devices
- Procedure coding for technology
- Diagnosis coding
- Payment mechanism for technology
- Reimbursement tariffs for technology
- Restrictions in indications or scenarios for use of technology
- Policy considerations by payers and policy-makers about technology
Reimbursement information is provided for the following geographies:
- Austria
- Belgium
- Denmark
- England (UK)
- France
- Germany
- Italy
- Netherlands
- Norway
- Sweden
- Switzerland
It is also possible to add analysis in Czech Republic, Finland, Hungary, Romania, Russia and Turkey.
Manufacturers of devices for heart valves (for open or thoracoscopic placement, not percutaneous)
- Abbott Vascular (Trifecta, SJM Regent, Epic™ Mitral)
- CryoLife Life Technologies, Inc. (On-X)
- Edwards Lifesciences (INSPIRIS RESILIA, EDWARDS INTUITY Elite, Carpentier-Edwards PERIMOUNT Magna-Ease)
- Labcor (Dokimos Plus)
- Lepu Medical (GK-3)
- LivaNova (Perceval, Crown PRT, Solo Smart, Mitroflow with PRT, Bicarbon Aortic Family, Carbomedic Aortic family)
- Medtronic (Avalus Bioprosthesis, Hancock II, Hancock II Ultra, Mosaic, Mosaic Ultra, Freestyle, Open Pivot)
- TTK Healthcare (Chitra)
Table of content is not available at the moment. Report is still ongoing.
14
Feb 2022
On January 28, 2022, the Institute for the Hospital Remuneration System (InEK) has published the list of the requests for innovation funding (NUB) that were submitted by the hospitals in 2021. The medical technologies belonging to the cardiovascular, ENT, eHealth, gastrointestinal, neuromodulation, neurovascular, orthopedic, and other technology groups obtained positive status 1.
Read more09
Dec 2021
In November 2021, the National Institute for Health and Care Excellence (NICE) published two new Interventional Procedure Guidance (percutaneous implantation of pulmonary artery pressure sensors in chronic heart failure and coronary sinus narrowing device implantation for refractory angina), one new Medical Technologies Guidance (Synergo for non-muscle-invasive bladder cancer), one new Diagnostic Guidance (SeHCAT for diagnosing bile acid diarrhea), and four new Medtech Innovation Briefings (clonoSEQ for minimal residual disease, CerebAir for continuous EEG monitoring, 24/7 EEG SubQ for epilepsy, Paige Prostate for prostate cancer). Also, three new clinical guidelines were published, and six were updated.
Read more16
Nov 2021
In late October 2021, the BfArM (Federal Institute for Drugs and Medical Devices) has published the final version of the 2022 OPS procedure coding classification. The OPS, together with the ICD-10-GM (International Statistical Classification of Diseases and Related Health Problems, 10th revision, German Modification), forms the basis for the reimbursement systems in outpatient and inpatient care.
Read more06
Jul 2021
In June 2021, the National Institute for Health and Care Excellence (NICE) published two new Interventional Procedure Guidance (laser lithotripsy for difficult-to-treat bile duct stones and percutaneous insertion of a closure device to repair a paravalvular leak around a replaced mitral or aortic valve), one new Medical Technologies Guidance (Plus Sutures for preventing surgical site infection), and four new Medtech Innovation Briefings (RapidAI for analyzing CT/MRI brain scans, WoundExpress, Magtrace and Sentimag, and SYNE-COV). Also, four clinical guidelines were updated, and two new published.
Read more08
Feb 2021
On January 29, 2021, the Institute for the Hospital Remuneration System (InEK) has published the List of the requests for innovation funding (NUB) that were submitted by the hospitals in 2020. The medical technologies belonging to the cardiovascular, ENT, eHealth, gastrointestinal, neuromodulation, neurovascular, orthopedic, and other technology groups obtained positive status 1.
Read more